We conclude that GSTT1null and GSTO2 (AG and GG) genotypes seem to increase the risk of B-ALL, whereas GSTM1, GSTP1, and GSTO1 polymorphisms had no role in the pathogenesis or therapeutic outcome of B-ALL. The gene discussed is GSTM1; the disease is precursor B-cell acute lymphoblastic leukemia.